Tag: RXII

Blue Horseshoe Stocks: ICLD Update & More

InterCloud Systems, Inc. ICLD

We’ve been tracking ICLD continuously since last Monday, and after witnessing a low of 3.01 and subsequent run to 4.30 that day (+43%), the stock turned in quite an admirable performance for the week as a whole.

Following a dip back to 3.01 on Tuesday, ICLD would register higher highs and higher lows all week, which provided some excellent swing-trade opportunities. Tuesday’s intraday run carried ICLD in a range from 3.01-4.00, for chances at up to 33% in gains. On Wednesday the move was from 3.11-3.75 (21%). Thursday’s session brought a similar 22% gain as it pushed from 3.35 to 4.09.

The great weekly performance culminated in a new high being set on Friday as the stock touched a low of 3.65 before reaching 4.48. It marked another nice intraday spike (+23%) and an overall increase of 49% over our observed low earlier in the week.

The stock has traded up to the 4.30’s here in the premarket, so we’ll have ICLD on our watchlist as we kick off a new trading week, and we’ll be interested to follow the action. We’ll also remind our readers that the company has a conference call scheduled for Wednesday, the info for which you can obtain by clicking through the link to the PR below.

SHREWSBURY, N.J., May 8, 2015 (GLOBE NEWSWIRE) — InterCloud Systems, Inc. (ICLD) (“InterCloud” or the “Company”), a single-source provider of end-to-end information technology (IT) and next-generation network solutions, to the service provider (carrier) and corporate enterprise markets, through cloud solutions and professional services will hold a conference call to discuss its financial results for the First Quarter 2015. CEO Mark Munro and CFO Tim Larkin will participate in the call >> FULL PR

Extended Watchlist:
CDTI (News), CANF, CERE, VGGL, RXII

Blue Horseshoe Stocks: PMCB Update & More

PharmaCyte Biotech, Inc. PMCB

When we released a special report on PMCB back on Tuesday of last week, we commented on the promising nature of trials the company currently has underway relating to various treatments based on its Cell-in-a-Box® technology.

At the end of last week, PharmaCyte announced some promising research specifically pertaining to its diabetes treatment, with the claim that it can actually reverse Type-1 Diabetes in mice.The full paper can be found at http://www.nature.com/articles/mtm201511. Human trials are the next step to take, and needless to say, should the treatment prove effective using PMCB’s encapsulation technology (that we described in our initial report,) acquisition by a large pharmaceutical company could become a very real possibility.

That also seems to be the thinking on the Street, as PMCB has made some impressive strides on the chart over the past several sessions. From the low of .12 that we observed in this play on 04/08, it has made its way up as high as .22; a respectable 83% overall increase. That impressive high came during yesterday’s session in conjunction with a breach of the current 200DMA of .19.

PMCB will be one that we want to keep on continuous watch due to its potentially industry-disruptive diabetes treatment.

Pazoo, Inc. PZOO

PZOO has been a flipper’s dream since we re-initiated coverage on it just a couple of weeks ago. Yesterday’s low registered as .008 before the stock bounced back to .0097, a 21% intraday swing.

It was the same story on Wednesday; we saw PZOO dip to a low of .0074 before returning as high as .0103 (+39%) We’ve continually stated that we’d like to see the stock trading at or above the .008 range which, for the most part, it has continued to do.

CEO David Cunic appeared in an audio interview yesterday, and this morning we’re seeing another PR directing our attention to an 8-K filing which outlines a recent agreement, among other things, so our readers might want to check out those links.

In the meantime, we’ll be on the lookout for upcoming intraday gain opportunities from PZOO, such as those that it has delivered numerous time over the past several sessions.

Identiv, Inc. INVE

We also want to make a quick mention of INVE, which made a solid 14% move yesterday as it traded in a range from 11.12-12.67. It came on over ten times the 3-month average volume, so we’ll be observing this one as the week draws to a close, and possibly into next week.

Extended Watchlist:
RXII, ONCY, ZBB, UNXL

Blue Horseshoe Stocks: FLST Update & New Bottom Play

Fuelstream, Inc. FLST

After we caught FLST and put it on watch as a bottom play yesterday, the stock offered up a chance at modest gains on an 29% intraday swing that took it from .0045 to .0058.

FLST managed to make higher highs and higher lows on Thursday, a good sign that it could be on its way to a more significant move. Should it achieve the same feat today, it could end up being a play that follow into next week.

Remember, we indicated the tight share structure on FLST yesterday, meaning that a relatively small amount of buying pressure could lead to a substantial increase.

The company also launched a new website yesterday. You can obtain more information there at www.thefuelstream.com.

Imperva, Inc. IMPV

We’ve got a new interest to bring forth this morning as well suggested to us by one of our faithful readers (Thanks for your input, D.J.!) The IMPV chart, which is coming off of its 52-week low, could be getting in in position to become a good recovery play. We’ve taken advantage of stocks coming off of annual lows several times in the past, so many of you know just how plentiful the chances for gains can be.

In the case of IMPV, as you can see on the chart we’ve included here, there are several aspects that would seem to indicate that a serious bounce could be in the making. The RSI is in heavily oversold territory, and in addition to a MACD that is just itching to make a bullish cross, there is a huge gap on the chart, the filling of which would lead to serious gains.

In addition to the possibility of using a rebound to profit on a big-board stock, we also like to explore the possibilities offered by the options chain. Presently we are looking at the Jun 21 and Sep 20 $30 Calls. The June’s closed at .60, and the September’s closed at 1.75 yesterday. Stay tuned, as we’re likely to be tracking this new play for quite some time.

Extended Watchlist:
BTCS, RXII, CYTR, EQU, SKUL, KCG